Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 739,900 | 813,100 | 842,300 | 642,800 | 718,900 |
| Cost of Goods | 291,300 | 317,100 | 341,400 | 239,800 | 276,700 |
| Gross Profit | 448,600 | 496,000 | 500,900 | 403,000 | 442,200 |
| Operating Expenses | 393,200 | 386,300 | 384,200 | 346,600 | 365,100 |
| Operating Income | 55,700 | 109,800 | 117,100 | 57,200 | 77,800 |
| Interest Expense | 34,800 | 35,000 | 36,600 | 34,900 | 32,200 |
| Other Income | 17,900 | 50,500 | -17,600 | 15,300 | 12,800 |
| Pre-tax Income | 38,800 | 125,300 | 62,900 | 37,600 | 58,400 |
| Income Tax | 14,800 | 50,200 | 26,800 | 15,200 | 23,600 |
| Net Income Continuous | 24,000 | 75,100 | 36,100 | 22,400 | 34,800 |
| Minority Interests | N/A | 0 | N/A | -100 | N/A |
| Net Income | $24,000 | $75,100 | $36,100 | $22,500 | $34,800 |
| EPS Basic Total Ops | 0.16 | 0.48 | 0.23 | 0.15 | 0.22 |
| EPS Basic Continuous Ops | 0.16 | 0.48 | 0.23 | 0.14 | 0.23 |
| EPS Diluted Total Ops | 0.16 | 0.48 | 0.23 | 0.14 | 0.23 |
| EPS Diluted Continuous Ops | 0.15 | 0.48 | 0.23 | 0.14 | 0.22 |
| EBITDA(a) | $108,100 | $161,800 | $169,200 | $105,200 | $124,100 |